European contribution to the science, prevention and management of HIV infection

T. Lehner; P. Biberfeld; C. Boucher; J. Darbyshire; E. M. Fenyo; J. L. Heeney; J. C. Jager; J. D. Lundgren; M. L. Newell; P. Rosch; P. Rossi; J. L. Virelizier

doi:10.1016/S0264-410X(97)00014-5

European contribution to the science, prevention and management of HIV infection

T. Lehner^*
, P. Biberfeld
, C. Boucher
, J. Darbyshire
, E. M. Fenyo
, J. L. Heeney
, J. C. Jager
, J. D. Lundgren
, M. L. Newell
, P. Rosch
, P. Rossi
, J. L. Virelizier

^*Corresponding author af dette arbejde

Abstract

The objectives of the European Commission Biomed AIDS Programme are to enable Europe to pool its intellectual and financial resources in the control, treatment and prevention of HIV infection and AIDS. In order to facilitate this aim the Commission has allocated 40 to 50 million ECU over the past 6 years for concerted action of the Biomed projects on AIDS by the countries of the European Union. This is only a small proportion of the real cost spent by the member countries on this epidemic.

Originalsprog	Engelsk
Tidsskrift	Vaccine
Vol/bind	15
Udgave nummer	5
Sider (fra-til)	465-468
Antal sider	4
ISSN	0264-410X
DOI	https://doi.org/10.1016/S0264-410X(97)00014-5
Status	Udgivet - 1997
Udgivet eksternt	Ja

Adgang til dokumentet

10.1016/S0264-410X(97)00014-5

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{20219ed3b1e34922b7f8bf97490a9163,

title = "European contribution to the science, prevention and management of HIV infection",

abstract = "The objectives of the European Commission Biomed AIDS Programme are to enable Europe to pool its intellectual and financial resources in the control, treatment and prevention of HIV infection and AIDS. In order to facilitate this aim the Commission has allocated 40 to 50 million ECU over the past 6 years for concerted action of the Biomed projects on AIDS by the countries of the European Union. This is only a small proportion of the real cost spent by the member countries on this epidemic.",

keywords = "AIDS, European commission, HIV",

author = "T. Lehner and P. Biberfeld and C. Boucher and J. Darbyshire and Fenyo, \{E. M.\} and Heeney, \{J. L.\} and Jager, \{J. C.\} and Lundgren, \{J. D.\} and Newell, \{M. L.\} and P. Rosch and P. Rossi and Virelizier, \{J. L.\}",

year = "1997",

doi = "10.1016/S0264-410X(97)00014-5",

language = "English",

volume = "15",

pages = "465--468",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd",

number = "5",

}

TY - JOUR

T1 - European contribution to the science, prevention and management of HIV infection

AU - Lehner, T.

AU - Biberfeld, P.

AU - Boucher, C.

AU - Darbyshire, J.

AU - Fenyo, E. M.

AU - Heeney, J. L.

AU - Jager, J. C.

AU - Lundgren, J. D.

AU - Newell, M. L.

AU - Rosch, P.

AU - Rossi, P.

AU - Virelizier, J. L.

PY - 1997

Y1 - 1997

N2 - The objectives of the European Commission Biomed AIDS Programme are to enable Europe to pool its intellectual and financial resources in the control, treatment and prevention of HIV infection and AIDS. In order to facilitate this aim the Commission has allocated 40 to 50 million ECU over the past 6 years for concerted action of the Biomed projects on AIDS by the countries of the European Union. This is only a small proportion of the real cost spent by the member countries on this epidemic.

AB - The objectives of the European Commission Biomed AIDS Programme are to enable Europe to pool its intellectual and financial resources in the control, treatment and prevention of HIV infection and AIDS. In order to facilitate this aim the Commission has allocated 40 to 50 million ECU over the past 6 years for concerted action of the Biomed projects on AIDS by the countries of the European Union. This is only a small proportion of the real cost spent by the member countries on this epidemic.

KW - AIDS

KW - European commission

KW - HIV

UR - https://www.scopus.com/pages/publications/0030903172

U2 - 10.1016/S0264-410X(97)00014-5

DO - 10.1016/S0264-410X(97)00014-5

M3 - Journal article

C2 - 9160511

AN - SCOPUS:0030903172

SN - 0264-410X

VL - 15

SP - 465

EP - 468

JO - Vaccine

JF - Vaccine

IS - 5

ER -

European contribution to the science, prevention and management of HIV infection

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater